Expedia
EXPE
234.96
-4.23
-1.77%
Expedia
US · EXPE
#650 by market cap
Listed 1970
234.96
-4.23
-1.77%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Recent news
-
Citi Maintains Expedia(EXPE.US) With Hold Rating, Cuts Target Price to $330\u5e02\u573a\u8d44\u8baf · 2026/11/6
-
Company notice
Intelligent Automation: Zhongyuan Securities Co., Ltd.\'s verification opinion on the use of raised funds by Wuxi Intelligent Automatic Control Engineering Co., Ltd. in place of self-raised funds previously invested in fund-raising projects and issued expeSZSI · 2023/9/14
-
Company notice
Wanbang Pharmaceutical: Verification Opinions of Minsheng Securities Co., Ltd. on Anhui Wanbang Pharmaceutical Technology Co., Ltd.\'s use of raised funds in exchange for self-financing of pre-invested fund-raising projects and pre-payment of issuance expeSZSI · 2023/11/16
-
A Quick Look at Today's Ratings for Expedia(EXPE.US), With a Forecast Between $320 to $430\u5e02\u573a\u8d44\u8baf · 2026/11/6
-
Argus Research Maintains Expedia(EXPE.US) With Buy Rating, Cuts Target Price to $300\u5e02\u573a\u8d44\u8baf · 2026/11/11
-
Company notice
HANG CHI HLDG: JOINT ANNOUNCEMENT(1) PROPOSED PRIVATISATION OF HANG CHI HOLDINGS LIMITEDBY THE OFFEROR BY WAY OF A SCHEME OF ARRANGEMENT(UNDER SECTION 86 OF THE COMPANIES ACT)(2) PROPOSED WITHDRAWAL OF LISTING OFHANG CHI HOLDINGS LIMITED(3) SANCTION OF THE SCHEME(4) EXPEHKEX · 2025/2/25
-
Rating change
Wells Fargo Maintains Expedia(EXPE.US) With Hold Rating, Cuts Target Price to $275\u5e02\u573a\u8d44\u8baf · 2026/10/7
-
Rating change
Melius Research Maintains Expedia(EXPE.US) With Buy Rating, Raises Target Price to $355\u5e02\u573a\u8d44\u8baf · 2026/10/20
-
Rating change
Baird Maintains Expedia(EXPE.US) With Buy Rating, Raises Target Price to $342\u5e02\u573a\u8d44\u8baf · 2026/10/27
-
Rating change
UBS Maintains Expedia(EXPE.US) With Hold Rating, Cuts Target Price to $328\u5e02\u573a\u8d44\u8baf · 2026/11/3
-
Bernstein Maintains Expedia(EXPE.US) With Hold Rating, Cuts Target Price to $261\u5e02\u573a\u8d44\u8baf · 2026/11/20
-
Rating change
Morgan Stanley Maintains Expedia(EXPE.US) With Sell Rating, Maintains Target Price $235\u5e02\u573a\u8d44\u8baf · 2026/11/6
-
Rating change
RBC Capital Maintains Expedia(EXPE.US) With Hold Rating, Maintains Target Price $330\u5e02\u573a\u8d44\u8baf · 2026/10/21
-
Rating change
BTIG Maintains Expedia(EXPE.US) With Buy Rating, Maintains Target Price $400\u5e02\u573a\u8d44\u8baf · 2026/10/6
-
B. Riley Securities Maintains Expedia(EXPE.US) With Buy Rating, Maintains Target Price $390\u5e02\u573a\u8d44\u8baf · 2026/11/13
-
Company notice
CHINA DILI: INSIDE INFORMATION (1) FURTHER DELAY IN PUBLICATION OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023, AND IN DESPATCH OF THE 2022 ANNUAL REPORT AND THE 2023 INTERIM REPORT; (2) EXPEHKEX · 2024/3/28
-
Rating change
Wells Fargo Maintains Expedia(EXPE.US) With Hold Rating, Maintains Target Price $275\u5e02\u573a\u8d44\u8baf · 2026/10/7
-
Rating change
A Quick Look at Today's Ratings for Expedia(EXPE.US), With a Forecast Between $320 to $400\u5e02\u573a\u8d44\u8baf · 2026/11/5
-
Company notice
JOINT ANNOUNCEMENT - PROPOSAL ON HANERGY THIN FILM POWER GROUP LIMITED BY HANERGY MOBILE ENERGY HOLDING GROUP CO., LTD*BY WAY OF A SCHEME OF ARRANGEMENT (UNDER SECTION 99 OF THE BERMUDA COMPANIES ACT) (1) SANCTION OF THE SCHEME BY THE COURTAND (2) EXPEHKEX · 2019/6/5
-
Rating change
Bernstein Maintains Expedia(EXPE.US) With Hold Rating, Maintains Target Price $310\u5e02\u573a\u8d44\u8baf · 2026/10/7
-
Rating change
Analysts Offer Insights on NA Companies: Expedia (EXPE) and BlossomHill Therapeutics, Inc. (BLSM)TipRanks · 2026/9/24
-
Earnings Flash (EXPE) Expedia Group, Inc. Reports Q3 Revenue $4.94B, Vs. FactSet Est of $4.73BMT Newswires · 2026/11/5
-
Rating change
Truist Financial Maintains Expedia(EXPE.US) With Hold Rating, Cuts Target Price to $288\u5e02\u573a\u8d44\u8baf · 2026/10/1
-
Rating change
Rosenblatt Securities Maintains Expedia(EXPE.US) With Hold Rating, Maintains Target Price $360\u5e02\u573a\u8d44\u8baf · 2026/9/1
-
Rating change
Morgan Stanley Downgrades Expedia(EXPE.US) to Sell Rating, Cuts Target Price to $235\u5e02\u573a\u8d44\u8baf · 2026/9/16
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:01:35 · For reference only, not investment advice and not tailored to your situation.
Expedia discussion 0 comments